Meta Health is expecting to report a net loss for the 1HFY2022 ended June.
The announcement on July 18 came after the group took a preliminary review of its unaudited consolidated financial results for the period.
The net loss was mainly due to a decrease in sales revenue on the back of the Covid-19-induced lockdown in Shanghai for close to two months.
The shortage of integrated circuit (IC) chips also affected customers’ demands.
In addition, the uncertainty in Europe due to the Russo-Ukraine war as well as the ongoing Sino-US trade war contributed to the lower sales revenue, says the group.
The group will announce its results on or before Aug 14.
Shares in Meta Health closed 0.2 cent lower or 6.45% down at 2.9 cents on July 18.